Détail d'une personne de l'annuaire - fr | Cancéropôle Est, la recherche innovante dans la lutte contre le cancer

Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.

Borel C, Sun XS, Coutte A, Bera G, Sire C, Zanetta S, Alfonsi M, Janoray G, Chatellier T, Garcia-Ramirez M, Gherga E, Hammoud Y, Burgy M, Etienne-Selloum N, Pechery A, Girard-Calais MH, Velten M, Pignon JP, Wanneveich M, Bourhis J

Radiother Oncol. 2024 05 18;:110329

Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.

Giannini M, Debrut L, Nespola B, Velten M, Geny B, Sibilia J, Meyer A

Nat Rev Rheumatol. 2024 03 21;:

Refining inflammatory myopathies incidence and characteristics: a quadruple source capture-recapture survey using 2017 ACR/EULAR criteria.

Debrut L, Giannini M, Klein D, Spielmann L, Mertz P, Martin T, Nadaj-Pakleza A, Hirschi S, Nespola B, Lannes B, Terzic J, Hinschberger O, Dervieux B, Lipsker D, Arnaud L, Gottenberg JE, Kleinmann JF, Geny B, Séverac F, Velten M, Sibilia J, Meyer A

Arthritis Rheumatol. 2023 05 16;:

Trends in incidence of invasive vaginal cancer in France from 1990 to 2018 and survival of recently diagnosed women - A population-based study.

Trétarre B, Dantony E, Coureau G, Defossez G, Guizard AV, Delafosse P, Daubisse L, Velten M, Karima Hammas, Barra S, Lapotre B, Plouvier S, d'Almeida T, Molinié F, Woronoff AS

Eur J Obstet Gynecol Reprod Biol. 2023 02 13;283:125-129

Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids.

Migueres N, Delmas C, Petit Thomas J, Kuntz H, Peri-Fontaa E, Schultz P, Velten M, de Blay F

Clin Transl Allergy. 2022 12;12(12):e12211

Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.

Martin S, Pflumio C, Trensz P, Schaff-Wendling F, Weindling MK, Fischbach C, Pierard L, Limacher JM, Nader R, Velten M, Petit T

Clin Breast Cancer. 2022 10 13;:

Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments.

Haidari RE, Anota A, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, Jolly D, Causeret S, Cuisenier J, Graesslin O, Abbas LA, Nerich V

Qual Life Res. 2022 05 19;:

Incidence and Trend of Type I and II Endometrial Cancer in Women from Two Population-Based European Cancer Registries (1998-2012).

Rodríguez-Palacios DÁ, Colorado-Yohar SM, Velten M, Vaamonde-Martín RJ, Ballesta M, Chirlaque MD

Int J Environ Res Public Health. 2022 Mar 23;19(7):

Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.

Mertes PM, Collange O, Coliat P, Banerjee M, Diringer MC, Roche A, Delabranche X, Chaban V, Voegelin M, Bernard A, Sartori V, Laurent N, Velten M, Dhindsa N, Defuria J, Kim G, Xu ZH, Theodorou M, Huang ZR, Khalifa K, Geng B, Niyikiza C, Moyo V, Gizzi P, Villa P, Detappe A, Pivot X

J Control Release. 2021 Jun 24;:

Cost-effectiveness analysis of resorbable biosynthetic mesh in contaminated ventral hernia repair.

Charleux-Muller D, Romain B, Boisson C, Velten M, Brigand C, Lejeune C

J Visc Surg. 2021 Jun 8;:

Anxiety during Radiation Therapy: A Prospective Randomized Controlled Trial Evaluating a Specific One-on-One Procedure Announcement Provided by a Radiation Therapist.

Antoni D, Vigneron C, Clavier JB, Guihard S, Velten M, Noel G

Cancers (Basel). 2021 May 24;13(11):

What is the most appropriate period to define synchronous cancers?

Baicry F, Molinié F, Plouvier S, Colonna M, Daubisse-Marliac L, Grosclaude P, Trétarre B, Bara S, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Marrer E, Klein D, Velten M, Jégu J

Cancer Epidemiol. 2021 Feb 9;71(Pt A):101900

Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.

Pabst L, Velten M, Fischbach C, Kalish M, Pflumio C, Pivot X, Petit T

Breast J. 2020 Dec 11;:

SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers.

Jannier S, Kemmel V, Sebastia Sancho C, Chammas A, Sabo AN, Pencreach E, Farace F, Chenard MP, Lhermitte B, Geoerger B, Aerts I, Frappaz D, Leblond P, André N, Ducassou S, Corradini N, Bertozzi AI, Guérin E, Vincent F, Velten M, Entz-Werle N

Cancers (Basel). 2020 Oct 20;12(10):

Evaluation of long-term living conditions in patients treated for localised prostate cancer.

Xiao D, Guizard AV, Daubisse-Marliac L, Woronoff AS, Trétarre B, Delafosse P, Molinié F, Cowppli-Bony A, Lapôtre-Ledoux B, Bara S, Marrer E, Velten M, Laroche L, Heutte N, Grosclaude P, Joly F

Eur J Cancer Care (Engl). 2020 Sep 24;:e13333

[Long-term occupational situation after cancer: A French registry-based study].

Saim A, Gernier F, Licaj I, Rod J, Velten M, Klein D, Mercier M, Joly F

Bull Cancer. 2020 Sep 9;:

Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN).

Bund V, Lecointre L, Velten M, Ouldamer L, Bendifallah S, Koskas M, Bolze PA, Collinet P, Canlorbe G, Touboul C, Huchon C, Coutant C, Faller E, Boisramé T, Gantzer J, Demarchi M, Baldauf JJ, Ballester M, Lavoué V, Akladios C

J Clin Med. 2020 Jul 29;9(8):

Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival.

Raze T, Lacour B, Cowppli-Bony A, Delafosse P, Velten M, Trétarre B, Defossez G, Hammas K, Woronoff AS, Ganry O, Plouvier S, Coureau G, Guizard AV, Bara S, Monnereau A, Daubisse-Marliac L, Troussard X, D'Almeida T, Baldi I, Bouvier V, Boissel N, Clavel J, Desandes E

J Adolesc Young Adult Oncol. 2020 May 15;:

Machine learning application for incident prostate adenocarcinomas automatic registration in a French regional regional cancer registry.

Fabacher T, Godet J, Klein D, Velten M, Jegu J

Int J Med Inform. 2020 Apr 9;139:104139

Cancer-related fatigue among long-term survivors of breast, cervical, and colorectal cancer: a French registry-based controlled study.

Gernier F, Joly F, Klein D, Mercier M, Velten M, Licaj I

Support Care Cancer. 2020 Apr 6;:

Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).

Lecointre L, Velten M, Lodi M, Saadeh R, Lavoué V, Ouldamer L, Bendifallah S, Koskas M, Bolze PA, Collinet P, Canlorbe G, Touboul C, Huchon C, Coutant C, Faller E, Boisramé T, Gantzer J, Martin D, Baldauf JJ, Akladios C, Ballester M

Eur. J. Obstet. Gynecol. Reprod. Biol.. 2019 Dec 6;245:64-72

Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients.

Herrscher H, Velten M, Leblanc J, Kalish-Weindling M, Fischbach C, Exinger D, Pivot X, Petit T

Breast Cancer Res. Treat.. 2019 Oct 14;:

Gastric MALT lymphoma in a population-based study in France: clinical features, treatments and survival.

Matysiak-Budnik T, Jamet P, Ruskoné-Fourmestraux A, de Mascarel A, Velten M, Maynadié M, Woronoff AS, Trétarre B, Marrer E, Delafosse P, Ligier K, Lapôtre Ledoux B, Daubisse L, Bouzid L, Orazio S, Cowppli-Bony A, Monnereau A

Aliment. Pharmacol. Ther.. 2019 Jul 26;:

Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.

Le Saux O, Lardy-Cleaud A, Frank S, Debled M, Cottu PH, Pistilli B, Vanlemmens L, Leheurteur M, Lévy C, Laborde L, Uwer L, D'hondt V, Berchery D, Lorgis V, Ferrero JM, Perrocheau G, Courtinard C, Mouret-Reynier MA, Velten M, Breton M, Parent D, Chabaud S, Robain M, Bachelot T

Eur. J. Cancer. 2019 Jul 19;118:131-141

Factors of the evolution of fatigue dimensions in patients with breast cancer during the 2 years after surgery.

Person H, Guillemin F, Conroy T, Velten M, Rotonda C

Int. J. Cancer. 2019 Jun 22;:

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).

Pérol D, Robain M, Arveux P, Mathoulin-Pélissier S, Chamorey E, Asselain B, Berchery D, Gourgou S, Breton M, Delaine-Clisant S, Mons M, Diéras V, Carton M, Guizard AV, Laborde L, Laurent C, Loeb A, Mouret-Reynier MA, Parent D, Perrocheau G, Campion L, Velten M, Cailliot C, Ezzalfani M, Simon G

BMJ Open. 2019 Feb 21;9(2):e023568

Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.

Seigneurin A, Delafosse P, Trétarre B, Woronoff AS, Velten M, Grosclaude P, Guizard AV, Lapôtre-Ledoux B, Bara S, Molinié F, Colonna M

BMC Cancer. 2018 Nov 12;18(1):1091

Epidemiology of Merkel Cell Carcinoma. A population-based study from 1985 to 2013, in Northeastern of France.

Kieny A, Cribier B, Meyer N, Velten M, Jégu J, Lipsker D

Int. J. Cancer. 2018 Sep 8;:

Adolescent and young adult oncology patients in France: Heterogeneity in pathways of care.

Desandes E, Brugières L, Molinié F, Defossez G, Delafosse P, Jehannin-Ligier K, Velten M, Trétarre B, Amadéo B, Marrer E, Woronoff AS, Ganry O, Monnereau A, d'Almeida T, Troussard X, Daubisse-Marliac L, Bara S, Guizard AV, Baldi I, Launoy G, Clavel J, Lacour B

Pediatr Blood Cancer. 2018 May 17;:e27235

Risk factors for salivary gland cancers in France: Results from a case-control study, the ICARE study.

Radoï L, Barul C, Menvielle G, Carton M, Matrat M, Sanchez M, Pilorget C, Velten M, Stücker I, Luce D,

Oral Oncol.. 2018 May;80:56-63

Use of a case-mix approach to study the trends in the incidence of second primary cancers.

Gass B, Marrer E, Bara S, Ligier K, Molinié F, Colonna M, Daubisse-Marliac L, Trétarre B, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Gaiddon C, Klein D, Velten M, Jégu J

Ann Epidemiol. 2018 May;28(5):322-327

Dietary habits during the 2 months following the Chernobyl accident and differentiated thyroid cancer risk in a population-based case-control study.

Xhaard C, Rubino C, Souchard V, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Woronoff AS, Velten M, Marrer E, Bailly L, Mariné Barjoan E, Schlumberger M, Drozdovitch V, Bouville A, Orgiazzi J, Adjadj E, de Vathaire F

Cancer Epidemiol. 2018 Feb;52:142-147

Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey.

Fondain M, Dereure O, Uhry Z, Guizard AV, Woronoff AS, Colonna M, Molinie F, Bara S, Velten M, Marrer E, Grosclaude P, Lapôtre-Ledoux B, Tretarre B, Guillot B

J Eur Acad Dermatol Venereol. 2018 Jan 16;:

Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy.

Collongues N, Samama B, Schmidt-Mutter C, Chamard-Witkowski L, Debouverie M, Chanson JB, Antal MC, Benardais K, de Seze J, Velten M, Boehm N

PLoS ONE. 2018 ;13(1):e0191614

Methodological issues of assessing the risk of a second cancer occurring in the same site as a first cancer using registry data.

Jégu J, Moitry M, Bara S, Trétarre B, Guizard AV, Woronoff AS, Daubisse-Marliac L, Bouvier V, Troussard X, Colonna M, Klein D, Lapôtre-Ledoux B, Velten M

Cancer Epidemiol. 2017 12;51:41-43

Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.

Baldauf JJ, Fender M, Bergeron C, Marrer E, Velten M, Pradat P, Arbyn M

Eur. J. Cancer Prev.. 2017 Nov 13;:

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.

Bignon L, Fricker JP, Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, Caron O, Lortholary A, Faivre L, Lasset C, Mari V, Gesta P, Gladieff L, Hamimi A, Petit T, Velten M

Breast J. 2017 Sep;:

Exposure to Farm Animals and Risk of Lung Cancer in the AGRICAN Cohort.

Tual S, Lemarchand C, Boulanger M, Dalphin JC, Rachet B, Marcotullio E, Velten M, Guizard AV, Clin B, Baldi I, Lebailly P

Am. J. Epidemiol.. 2017 Aug;186(4):463-472

Cancer incidence in the AGRICAN cohort study (2005-2011).

Lemarchand C, Tual S, Levêque-Morlais N, Perrier S, Belot A, Velten M, Guizard AV, Marcotullio E, Monnereau A, Clin B, Baldi I, Lebailly P,

Cancer Epidemiol. 2017 Jul;49:175-185

Reporting reactive cellular changes on smears among women who undergo cervical cancer screening: results of a cohort study after seven years of follow-up.

Moitry M, Jégu J, Averous G, Velten M, Fender M, Akladios C, Baldauf JJ

Eur. J. Obstet. Gynecol. Reprod. Biol.. 2017 Jul;216:232-238

Are dietary reports in a case-control study on thyroid cancer biased by risk perception of Chernobyl fallout?

Xhaard C, Dumas A, Souchard V, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Wonoroff AS, Velten M, Clero E, Maillard S, Marrer E, Bailly L, Mariné Barjoan E, Schlumberger M, Orgiazzi J, Adjadj E, Rubino C, Bouville A, Drozdovitch V, de Vathaire F

Rev Epidemiol Sante Publique. 2017 Jun;:

Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.

Addeo P, Velten M, Averous G, Faitot F, Nguimpi-Tambou M, Nappo G, Felli E, Fuchshuber P, Bachellier P

Surgery. 2017 May;:

Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors.

Moitry M, Velten M, Trétarre B, Bara S, Daubisse-Marliac L, Lapôtre-Ledoux B, Troussard X, Molinié F, Ligier K, Woronoff AS, Bouvier V, Colonna M, Klein D, Guizard AV, Jégu J

Cancer Epidemiol. 2017 Apr;47:35-41

Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?

Beck M, Michel B, Rybarczyk-Vigouret MC, Sordet C, Sibilia J, Velten M

Eur J Hosp Pharm Sci Pract. 2017 Mar;24(2):85-90

Agricultural exposure and risk of bladder cancer in the AGRIculture and CANcer cohort.

Boulanger M, Tual S, Lemarchand C, Guizard AV, Velten M, Marcotullio E, Baldi I, Clin B, Lebailly P

Int Arch Occup Environ Health. 2017 Feb;90(2):169-178

Oral cancer characteristics in France: Descriptive epidemiology for early detection.

Jéhannin-Ligier K, Dejardin O, Lapôtre-Ledoux B, Bara S, Coureau G, Grosclaude P, Marrer E, Molinié F, Trétarre B, Velten M, Woronoff AS, Colonna M, Guizard AV

J Stomatol Oral Maxillofac Surg. 2017 Feb;:

Incidence of solitary pulmonary nodules in Northeastern France: a population-based study in five regions.

Marrer É, Jolly D, Arveux P, Lejeune C, Woronoff-Lemsi MC, Jégu J, Guillemin F, Velten M

BMC Cancer. 2017 Jan;17(1):47

Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.

Anota A, Mariet AS, Maingon P, Joly F, Bosset JF, Guizard AV, Bittard H, Velten M, Mercier M

Health Qual Life Outcomes. 2016 Dec;14(1):168

Impact of Prosthesis-Patient Mismatch on Long-term Functional Capacity After Mechanical Aortic Valve Replacement.

Petit-Eisenmann H, Epailly E, Velten M, Radojevic J, Eisenmann B, Kremer H, Kindo M

Can J Cardiol. 2016 Dec;32(12):1493-1499

Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time.

Ousmen A, Conroy T, Guillemin F, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Hamidou Z, Bonnetain F, Anota A

Health Qual Life Outcomes. 2016 Dec;14(1):167

Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey.

Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M,

BioDrugs. 2016 Dec;30(6):585-592

Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.

Neumann F, Jégu J, Mougin C, Prétet JL, Guizard AV, Lapôtre-Ledoux B, Bara S, Bouvier V, Colonna M, Troussard X, Trétarre B, Grosclaude P, Velten M, Woronoff AS

Prev Med. 2016 Sep;90:52-8

Brief Report: Spatial Heterogeneity of Systemic Sclerosis in France: High Prevalence in the Northeast Region.

Meyer A, Chifflot H, Chatelus E, Kleinmann JF, Ronde-Ousteau C, Klein D, Jégu J, Geny B, Hirshi S, Canuet M, Blaison G, Kieffer P, Lipsker D, Martin T, Sauleau E, Velten M, Sibilia J

. 2016 Jul;68(7):1731-7

Recreational Physical Activity and Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.

Xhaard C, Lence-Anta JJ, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Danzon A, Velten M, Clero E, Maillard S, Marrer E, Bailly L, Mariné Barjoan E, Schlumberger M, Orgiazzi J, Adjadj E, Pereda CM, Turcios S, Velasco M, Chappe M, Infante I, Bustillo M, García A, Salazar S, Rodriguez R, Benadjaoud MA, Ortiz RM, Rubino C, de Vathaire F

Eur Thyroid J. 2016 Jul;5(2):132-8

Long-Term Follow-Up of Quality of Life following DIEP Flap Breast Reconstruction.

Hunsinger V, Hivelin M, Derder M, Klein D, Velten M, Lantieri L

Plast. Reconstr. Surg.. 2016 May;137(5):1361-71

Long-term storage and safe retrieval of human papillomavirus DNA using FTA elute cards.

Barth H, Morel A, Mougin C, Averous G, Legrain M, Fender M, Risch S, Fafi-Kremer S, Velten M, Oudet P, Baldauf JJ, Stoll-Keller F

J. Virol. Methods. 2016 Mar;229:60-5

Prostate cancer risk among French farmers in the AGRICAN cohort.

Lemarchand C, Tual S, Boulanger M, Levêque-Morlais N, Perrier S, Clin B, Guizard AV, Velten M, Rigaud E, Baldi I, Lebailly P

Scand J Work Environ Health. 2016 Mar;42(2):144-52

Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.

Trétarre B, Molinié F, Woronoff AS, Bossard N, Bessaoud F, Marrer E, Grosclaude P, Guizard AV, Delafosse P, Bara S, Velten M, Lapôtre-Ledoux B, Ligier K, Léone N, Arveux P, Uhry Z

Gynecol. Oncol.. 2015 Nov;139(2):324-9

Trends of the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10,047 patients.

Muller J, Grosclaude P, Lapotre-Ledoux B, Woronoff AS, Guizard AV, Bara S, Colonna M, Troussard X, Bouvier V, Tretarre B, Velten M, Jegu J

BJU Int. 2015 Oct 15

Analysis and Breakdown of Overall 1-Year Costs Relative to Inpatient and Outpatient Care Among Rheumatoid Arthritis Patients Treated with Biotherapies Using Health Insurance Claims Database in Alsace.

Beck M, Velten M, Rybarczyk-Vigouret MC, Covassin J, Sordet C, Michel B

Drugs Real World Outcomes. 2015 Sep;2(3):205-215

Anthropometric Risk Factors for Differentiated Thyroid Cancer in Young Men and Women From Eastern France: A Case-Control Study.

Xhaard C, de Vathaire F, Clero E, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Danzon A, Velten M, Marrer E, Bailly L, Barjoan EM, Schlumberger M, Orgiazzi J, Adjadj E, Rubino C

Am J Epidemiol. 2015 Aug 1;182(3):202-14

[Prostate cancer incidence and mortality trends in France from 1980 to 2011].

Grosclaude P, Belot A, Daubisse Marliac L, Remontet L, Leone N, Bossard N, Velten M

Prog Urol. 2015 Jun 1. pii: S1166-7087(15)00137-2

Modern Treatments in Advanced Non-Small-Cell Lung Cancer: Temporal Trends and Effect on Survival. A French Population-Based Study.

Carpentier O, Selvaggi L, Jegu J, Purohit A, Prim N, Velten M, Quoix E

Clin Lung Cancer. 2015 May 13. pii: S1525-7304(15)00119-9

Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.

Jegu J, Belot A, Borel C, Daubisse-Marliac L, Tretarre B, Ganry O, Guizard AV, Bara S, Troussard X, Bouvier V, Woronoff AS, Colonna M, Velten M

Oral Oncol. 2015 Feb 13. pii: S1368-8375(15)00022-6

Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma.

Rossi C, Jegu J, Mounier M, Dandoit M, Colonna M, Daubisse-Marliac L, Tretarre B, Ganry O, Guizard AV, Bara S, Bouvier V, Woronoff AS, Monnereau A, Casasnovas O, Velten M, Troussard X, Maynadie M

Leuk Lymphoma. 2015 Feb 2:1-23.

Coffee consumption and risk of lung cancer: the ICARE study.

Sanikini H, Radoi L, Menvielle G, Guida F, Mattei F, Cenee S, Cyr D, Sanchez M, Velten M, Carton M, Schmaus A, Luce D, Stucker I

Eur J Epidemiol. 2015 Jan;30(1):81-5

Occupational Exposure to Diesel Motor Exhaust and Lung Cancer: A Dose-Response Relationship Hidden by Asbestos Exposure Adjustment? The ICARE Study.

Matrat M, Guida F, Cenee S, Fevotte J, Carton M, Cyr D, Menvielle G, Paget-Bailly S, Radoi L, Schmaus A, Bara S, Velten M, Luce D, Stucker I, The Icare Study Group

J Cancer Epidemiol. 2015;2015:879302

Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study.

Xhaard C, Rubino C, Clero E, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Danzon A, Velten M, Buemi A, Bailly L, Marine Barjoan E, Schlumberger M, Orgiazzi J, Adjadj E, de Vathaire F

Am J Epidemiol. 2014 Nov 15;180(10):1007-17

Role of thyroid surgery in the obstructive sleep apnea syndrome.

Schneider A, Bourahla K, Petiau C, Velten M, Volkmar PP, Rodier JF

World J Surg. 2014 Aug;38(8):1990-4

0206 Prostate cancer risk among French farmers in the AGRICAN cohort.

Lemarchand C, Tual S, Leveque-Morlais N, Perrier S, Guizard AV, Velten M, Rigaud E, Baldi I, Lebailly P

Occup Environ Med. 2014 Jun;71 Suppl 1:A86-7

Asthma among workers in healthcare settings: role of disinfection with quaternary ammonium compounds.

Gonzalez M, Jegu J, Kopferschmitt MC, Donnay C, Hedelin G, Matzinger F, Velten M, Guilloux L, Cantineau A, de Blay F

Clin Exp Allergy. 2014 Mar;44(3):393-406

Impact of response shift on time to deterioration in quality of life scores in breast cancer patients.

Hamidou Z, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, Jolly D, Causeret S, Graesslin O, Gauthier M, Mercier M, Bonnetain F

PLoS One. 2014 May 14;9(5):e96848

Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients.

Anota A, Bascoul-Mollevi C, Conroy T, Guillemin F, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Hamidou Z, Bonnetain F

Health Qual Life Outcomes. 2014 Mar 8;12:32

Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients' survival.

Lemonnier I, Guillemin F, Arveux P, Clement-Duchene C, Velten M, Woronoff-Lemsi MC, Jolly D, Baumann C

Health Qual Life Outcomes. 2014 May 15;12:73

Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology.

Quantin C, Benzenine E, Velten M, Huet F, Farrington CP, Tubert-Bitter P

Am J Epidemiol. 2013 Dec 15;178(12):1731-9

Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles/mumps/rubella immunization.

Hanf M, Quantin C, Farrington P, Benzenine E, Hocine NM, Velten M, Tubert-Bitter P, Escolano S

Vaccine. 2013 Dec 2;31(49):5856-62

[Incidence and mortality of urological cancers in 2012 in France].

Rebillard X, Grosclaude P, Leone N, Velten M, Coureau G, Villers A, Irani J, Lebret T, Rigaud J, Pfister C, Patard JJ, Richaud P, Salomon L, Coloby P, Soulie M

Prog Urol. 2013 Nov;23 Suppl 2:S57-65

Distinctive features of melanoma and its management in elderly patients: a population-based study in France.

Ciocan D, Barbe C, Aubin F, Granel-Brocard F, Lipsker D, Velten M, Dalac S, Truchetet F, Michel C, Mitschler A, Arnoult G, Buemi A, Dalle S, Bernard P, Woronoff AS, Grange F

JAMA Dermatol. 2013 Oct;149(10):1150-7

Occupation and head and neck cancer risk in men: results from the ICARE study, a French population-based case-control study.

Paget-Bailly S, Guida F, Carton M, Menvielle G, Radoi L, Cyr D, Schmaus A, Cenee S, Papadopoulos A, Fevotte J, Pilorget C, Velten M, Guizard AV, Stucker I, Luce D

J Occup Environ Med. 2013 Sep;55(9):1065-73

Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.

Crocetti E, Caldarella A, Ferretti S, Ardanaz E, Arveux P, Bara S, Barrios E, Bento MJ, Bordoni A, Buzzoni C, Candela G, Colombani F, Delafosse P, Federico M, Francart J, Giacomin A, Grosclaude P, Guizard AV, Izarzugaza I, Konzelmann I, La Rosa F, Lapotre B, Leone N, Ligier K, Mangone L, Marcos-Gragera R, Martinez R, Michelena MJ, Michiara M, Miranda A, Molinie F, Mugarza-Gomez C, Paci E, Piffer S, Puig-Vives M, Sacchettini C, Sanchez MJ, Traina A, Tretarre B, Tumino R, Van Vaerenbergh E, Velten M, Woronoff AS

Breast. 2013 Aug;22(4):476-81

Life expectancy estimates as a key factor in over-treatment: the case of prostate cancer.

Delpierre C, Lamy S, Kelly-Irving M, Molinie F, Velten M, Tretarre B, Woronoff AS, Buemi A, Lapotre-Ledoux B, Bara S, Guizard AV, Colonna M, Grosclaude P

Cancer Epidemiol. 2013 Aug;37(4):462-8

Tea and coffee consumption and risk of oral cavity cancer: results of a large population-based case-control study, the ICARE study.

Radoi L, Paget-Bailly S, Menvielle G, Cyr D, Schmaus A, Carton M, Guida F, Cenee S, Sanchez M, Guizard AV, Velten M, Stucker I, Luce D

Cancer Epidemiol. 2013 Jun;37(3):284-9

Cancer incidence and survival in adolescents and young adults in France, 2000-2008.

Desandes E, Lacour B, Belot A, Molinie F, Delafosse P, Tretarre B, Velten M, Sauleau EA, Woronoff AS, Guizard AV, Ganry O, Bara S, Grosclaude P, Troussard X, Bouvier V, Brugieres L, Clavel J

Pediatr Hematol Oncol. 2013 May;30(4):291-306

Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.

Roche L, Danieli C, Belot A, Grosclaude P, Bouvier AM, Velten M, Iwaz J, Remontet L, Bossard N

Int J Cancer. 2013 May 15;132(10):2359-69

Lipoprotein(a) plasma levels and the risk of cancer: the PRIME study.

Marrer E, Wagner A, Montaye M, Luc G, Amouyel P, Dallongeville J, Ducimetiere P, Bingham A, Arveiler D, Velten M

Eur J Cancer Prev. 2013 May;22(3):286-93

Quality of life in long-term cervical cancer survivors: a population-based study.

Le Borgne G, Mercier M, Woronoff AS, Guizard AV, Abeilard E, Caravati-Jouvenceaux A, Klein D, Velten M, Joly F

Gynecol Oncol. 2013 Apr;129(1):222-8

Breast cancer survival in the US and Europe: a CONCORD high-resolution study.

Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, Siesling S, Torrella-Ramos A, Voogd AC, Aareleid T, Ardanaz E, Berrino F, Bielska-Lasota M, Bolick S, Cirilli C, Colonna M, Contiero P, Cress R, Crocetti E, Fulton JP, Grosclaude P, Hakulinen T, Izarzugaza MI, Malmstrom P, Peignaux K, Primic-Zakelj M, Rachtan J, Safaei Diba C, Sanchez MJ, Schymura MJ, Shen T, Traina A, Tryggvadottir L, Tumino R, Velten M, Vercelli M, Wolf HJ, Woronoff AS, Wu X, Coleman MP

Int J Cancer. 2013 Mar 1;132(5):1170-81

Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.

Dabakuyo TS, Guillemin F, Conroy T, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Gauthier M, Bonnetain F

Qual Life Res. 2013 Feb;22(1):1-11

Cross-cultural French adaptation and validation of the Impact On Family Scale (IOFS).

Boudas R, Jegu J, Grollemund B, Quentel E, Danion-Grilliat A, Velten M

Health Qual Life Outcomes. 2013 Apr 23;11:67

Factors associated with fatigue after surgery in women with early-stage invasive breast cancer.

Rotonda C, Guillemin F, Bonnetain F, Velten M, Conroy T

Oncologist. 2013;18(4):467-75

Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.

Jegu J, Binder-Foucard F, Borel C, Velten M

Oral Oncol. 2013 Jan;49(1):9-14

Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France.

Grange F, Barbe C, Aubin F, Lipsker D, Granel-Brocard F, Velten M, Dalac S, Truchetet F, Michel C, Mitschler A, Arnoult G, Buemi A, Dalle S, Bernard P, Woronoff AS

Arch Dermatol. 2012 Dec;148(12):1370-6.

The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France.

Grange F, Barbe C, Mas L, Granel-Brocard F, Lipsker D, Aubin F, Velten M, Dalac S, Truchetet F, Michel C, Mitschler A, Arnoult G, Buemi A, Dalle S, Reuter G, Bernard P, Woronoff AS, Arnold F

Br J Dermatol. 2012 Dec;167(6):1351-9

Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Gaudineau A, Weitbruch D, Quetin P, Heymann S, Petit T, Volkmar P, Bodin F, Velten M, Rodier JF

Oncol Lett. 2012 Oct;4(4):719-722

Use of psychotropic drugs, systemic antihistamines and medications for cough in 6-year-old children: a survey in the Bas-Rhin Region, France.

Binder-Foucard F, Reitzer C, Jegu J, Schweitzer B, Koehl F, Kopferschmitt J, Velten M

Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1112-7

Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas.

Caillard S, Lamy FX, Quelen C, Dantal J, Lebranchu Y, Lang P, Velten M, Moulin B

Am J Transplant. 2012 Mar;12(3):682-93

Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.

Mouracade P, Velten M, Gigante M, Alenda O, Ploussard G, Obadia F, Timsit MO, Mejean A

Can J Urol. 2012 Feb;19(1):6105-10.

Relational development in children with cleft lip and palate: influence of the waiting period prior to the first surgical intervention and parental psychological perceptions of the abnormality.

Grollemund B, Guedeney A, Vazquez MP, Picard A, Soupre V, Pellerin P, Simon E, Velten M, Dissaux C, Kauffmann I, Bruant-Rodier C, Danion-Grilliat A

BMC Pediatr. 2012 Jun 8;12:65

Long-term quality of life after breast cancer: a French registry-based controlled study.

Klein D, Mercier M, Abeilard E, Puyraveau M, Danzon A, Dalstein V, Pozet A, Guizard AV, Henry-Amar M, Velten M

Breast Cancer Res Treat. 2011 Aug;129(1):125-34

Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.

Rogel A, Belot A, Suzan F, Bossard N, Boussac M, Arveux P, Buemi A, Colonna M, Danzon A, Ganry O, Guizard AV, Grosclaude P, Velten M, Jougla E, Iwaz J, Esteve J, Cherie-Challine L, Remontet L

Cancer Epidemiol. 2011 Jun;35(3):243-9

[Epidemiology of oral cavity cancers in France].

Ligier K, Belot A, Launoy G, Velten M, Delafosse P, Guizard AV

Rev Stomatol Chir Maxillofac. 2011 Jun;112(3):164-71

[Is early cervical cancer screening justified?].

Baldauf JJ, Fender M, Akladios CY, Velten M

Gynecol Obstet Fertil. 2011 Jun;39(6):358-63

Cost of pretherapeutic staging of patients with colorectal cancer metastases in a French population.

Lejeune C, Loge P, Arveux P, Velten M, Jolly D, Woronoff-Lemsi MC, Guillemin F

Clin Res Hepatol Gastroenterol. 2011 May;35(5):399-407

Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010.

Ligier K, Belot A, Launoy G, Velten M, Bossard N, Iwaz J, Righini CA, Delafosse P, Guizard AV

Oral Oncol. 2011 Apr;47(4):302-7.

Solitary pulmonary nodules: consequences for patient quality of life.

Lemonnier I, Baumann C, Jolly D, Arveux P, Woronoff-Lemsi MC, Velten M, Guillemin F

Qual Life Res. 2011 Feb;20(1):101-9

Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer.

Petit T, Wilt M, Velten M, Rodier JF, Fricker JP, Dufour P, Ghnassia JP

Breast Cancer Res Treat. 2010 Nov;124(2):387-91

What reasons lie behind long-term survival differences for gastric cancer within Europe?

Bouvier AM, Sant M, Verdecchia A, Forman D, Damhuis R, Willem Coebergh J, Crocetti E, Crosignani P, Gafa L, Launoy G, Martinez-Garcia C, Plesko I, Pompe-Kirn V, Rachtan J, Velten M, Vercelli M, Zwierko M, Esteve J, Faivre J

Eur J Cancer. 2010 Apr;46(6):1086-92

A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.

Phelip JM, Molinie F, Delafosse P, Launoy G, Tretarre B, Bara S, Buemi A, Velten M, Danzon A, Ganry O, Bouvier AM, Grosclaude P, Faivre J

Gastroenterol Clin Biol. 2010 Feb;34(2):144-9

Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005.

Le Stang N, Belot A, Gilg Soit Ilg A, Rolland P, Astoul P, Bara S, Brochard P, Danzon A, Delafosse P, Grosclaude P, Guizard AV, Imbernon E, Lapotre-Ledoux B, Ligier K, Molinie F, Pairon JC, Sauleau EA, Tretarre B, Velten M, Bossard N, Goldberg M, Launoy G, Galateau-Salle F

Int J Cancer. 2010 Jan 1;126(1):232-8.

[Prostate cancer management and factors associated with radical prostatectomy in France in 2001]

Jegu J, Tretarre B, Velten M, Guizard AV, Danzon A, Buemi A, Colonna M, Kadi-Hanifi AM, Ganry O, Molinie F, Bara S, Rebillard X, Grosclaude P

Prog Urol. 2010 Jan;20(1):56-64

[Time trends in the geographic variation of thyroid cancer incidence by tumor size from 1983 to 2000 in France]

Leux C, Colonna M, Guizard AV, Uhry Z, Velten M, Ganry O, Schvartz C, Grosclaude P, Molinie F

Rev Epidemiol Sante Publique. 2009 Dec;57(6):403-10

[Current management and prognosis of intrahepatic cholangiocarcinoma in France]

Borie F, Niampa H, Bouvier AM, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P, Tretarre B

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):971-6

[Estimating the incidence of colorectal cancer in France from a hospital discharge database, 1999-2003]

Uhry Z, Remontet L, Grosclaude P, Velten M, Colonna M

Rev Epidemiol Sante Publique. 2009 Oct;57(5):329-36

Should psychological events be considered cancer risk factors?

Schraub S, Sancho-Garnier H, Velten M

Rev Epidemiol Sante Publique. 2009 Apr;57(2):113-23

Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France.

Lemonnier I, Baumann C, Jay N, Alzahouri K, Arveux P, Jolly D, Lejeune C, Velten M, Vitry F, Woronoff-Lemsi MC, Guillemin F

BMC Cancer. 2009 May 11;9:139.

Prostate cancer treatment in Europe at the end of 1990s.

Gatta G, Zigon G, Buemi A, Coebergh JW, Colonna M, Contiero P, Denis L, Grosclaude P, Guizard AV, Sanchez-Perez MJ, Plesko I, Ondrusova M, Rachtan J, Valdagni R, Velten M, Vercelli M, Berrino F

Acta Oncol. 2009;48(6):867-73.

Treatment and prognosis of hepatocellular carcinoma: a population based study in France.

Borie F, Bouvier AM, Herrero A, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P, Tretarre B

J Surg Oncol. 2008 Dec 1;98(7):505-9.

Factors associated with overall and attributable mortality in invasive aspergillosis.

Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Ame S, Fohrer C, Lioure B, Bilger K, Lutun P, Marcellin L, Launoy A, Freys G, Bergerat JP, Herbrecht R

Clin Infect Dis. 2008 Nov 1;47(9):1176-84

Cancer incidence and mortality in France over the period 1980-2005.

Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinie F, Danzon A, Bara S, Bouvier AM, Tretarre B, Binder-Foucard F, Colonna M, Daubisse L, Hedelin G, Launoy G, Le Stang N, Maynadie M, Monnereau A, Troussard X, Faivre J, Collignon A, Janoray I, Arveux P, Buemi A, Raverdy N, Schvartz C, Bovet M, Cherie-Challine L, Esteve J, Remontet L, Velten M

Rev Epidemiol Sante Publique. 2008 Jun;56(3):159-75

Prognostic factors of survival in head and neck cancer patients treated with surgery and postoperative radiation therapy.

Le Tourneau C, Jung GM, Borel C, Bronner G, Flesch H, Velten M

Acta Otolaryngol. 2008 Jun;128(6):706-12.

Trends in incidence of digestive cancers in France

Lepage C, Remontet L, Launoy G, Tretarre B, Grosclaude P, Colonna M, Velten M, Buemi A, Danzon A, Molinie F, Maarouf N, Bossard N, Bouvier AM, Faivre J

Eur J Cancer Prev. 2008 Feb;17(1):13-7.

Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012.

Colonna M, Danzon A, Delafosse P, Mitton N, Bara S, Bouvier AM, Ganry O, Guizard AV, Launoy G, Molinie F, Sauleau EA, Schvartz C, Velten M, Grosclaude P, Tretarre B

Eur J Cancer. 2008 Jan;44(1):115-22

Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts.

Alzahouri K, Velten M, Arveux P, Woronoff-Lemsi MC, Jolly D, Guillemin F

BMC Cancer. 2008 Apr 10;8:93.

The influence of socio-economic and surveillance characteristics on breast cancer survival: a French population-based study

Gentil-Brevet J, Colonna M, Danzon A, Grosclaude P, Chaplain G, Velten M, Bonnetain F, Arveux P

Br J Cancer. 2008 Jan 15;98(1):217-24.

Epidemiology of hepatocellular carcinoma in Bas-Rhin: analysis of all incident cases from 1990 to 1999

Binder-Foucard F, Doffoel M, Velten M

Gastroenterol Clin Biol. 2007 Oct;31(10):838-43.

Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.

Rodier JF, Velten M, Wilt M, Martel P, Ferron G, Vaini-Elies V, Mignotte H, Bremond A, Classe JM, Dravet F, Routiot T, de Lara CT, Avril A, Lorimier G, Fondrinier E, Houvenaeghel G, Avigdor S

J Clin Oncol. 2007 Aug 20;25(24):3664-9

Trends in melanoma epidemiology suggest three different types of melanoma.

Lipsker D, Engel F, Cribier B, Velten M, Hedelin G

Br J Dermatol. 2007 Aug;157(2):338-43

Specific features of non-small cell lung cancer in women: A retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997

Foegle J, Hedelin G, Lebitasy MP, Purohit A, Velten M, Quoix E

J Thorac Oncol. 2007 Jun;2(6):466-74.

Cancer incidence and survival among adolescents and young adults in France (1978-1997)

Desandes E, Lacour B, Belot A, White-Koning M, Velten M, Tretarre B, Sauleau EA, Maarouf N, Guizard AV, Delafosse P, Danzon A, Cotte C, Boutreux S, Brugieres L

Bull Cancer. 2007 Apr 1;94(4):331-7.

A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000).

Colonna M, Guizard AV, Schvartz C, Velten M, Raverdy N, Molinie F, Delafosse P, Franc B, Grosclaude P

Eur J Cancer. 2007 Mar;43(5):891-900

Place of multidisciplinary consulting meetings and clinical trials in the management of colorectal cancer in France in 2000

Bouvier AM, Bauvin E, Danzon A, Grosclaude P, Delafosse P, Buemi A, Tretarre B, Raverdy N, Maarouf N, Velten M, Launoy G, Faivre J

Gastroenterol Clin Biol. 2007 Mar;31(3):286-91.

Cancer adolescent pathway in France between 1988 and 1997

Desandes E, Lacour B, Sommelet D, White-Koning M, Velten M, Tretarre B, Marr A, Maarouf N, Guizard AV, Delafosse P, Danzon A, Cotte C, Brugieres L

Eur J Oncol Nurs. 2007 Feb;11(1):74-81

Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database.

Uhry Z, Colonna M, Remontet L, Grosclaude P, Carre N, Couris CM, Velten M

Eur J Epidemiol. 2007;22(9):607-14

Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.

Petit T, Velten M, d'Hombres A, Marchal C, Montbarbon X, Mornex F, Quetin P, Gerard JP, Romestaing P, Carrie C

Gynecol Oncol. 2007 Jan;104(1):104-8

Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).

Bossard N, Velten M, Remontet L, Belot A, Maarouf N, Bouvier AM, Guizard AV, Tretarre B, Launoy G, Colonna M, Danzon A, Molinie F, Troussard X, Bourdon-Raverdy N, Carli PM, Jaffre A, Bessaguet C, Sauleau E, Schvartz C, Arveux P, Maynadie M, Grosclaude P, Esteve J, Faivre J

Eur J Cancer. 2007 Jan;43(1):149-60

Socioeconomic and geographic determinants of survival of patients with digestive cancer in France.

Dejardin O, Remontet L, Bouvier AM, Danzon A, Tretarre B, Delafosse P, Molinie F, Maarouf N, Velten M, Sauleau EA, Bourdon-Raverdy N, Grosclaude P, Boutreux S, De Pouvourville G, Launoy G

Br J Cancer. 2006 Oct 9;95(7):944-9

Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.

Andresz V, Marcantoni N, Binder F, Velten M, Alt M, Weber JC, Stephan D

Addiction. 2006 Sep;101(9):1347-51.

[Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroid cancer (1999-2000)].

Carre N, Uhry Z, Velten M, Tretarre B, Schvartz C, Molinie F, Maarouf N, Langlois C, Grosclaude P, Colonna M

Rev Epidemiol Sante Publique. 2006 Sep;54(4):367-76.

Epidemiology of juvenile idiopathic arthritis in Alsace, France.

Danner S, Sordet C, Terzic J, Donato L, Velten M, Fischbach M, Sibilia J

J Rheumatol. 2006 Jul;33(7):1377-81.

[The progression of lung cancer incidence in France (1978-2000)].

Molinie F, Velten M, Remontet L, Bercelli P, Reseau Francim

Rev Mal Respir. 2006 Apr;23(2 Pt 1):127-34.

Cancer survival among adolescents in France.

Desandes E, Lacour B, Sommelet D, Danzon A, Delafosse P, Grosclaude P, Mace-Lesech J, Maarouf N, Marr A, Raverdy-Bourdon N, Tretarre B, Velten M, Brugieres L

Eur J Cancer. 2006 Feb;42(3):403-9

Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases.

Le Tourneau C, Velten M, Jung GM, Bronner G, Flesch H, Borel C

Head Neck. 2005 Sep;27(9):801-8.

Social and geographic disparities in access to reference care site for patients with colorectal cancer in France.

Dejardin O, Bouvier AM, Herbert C, Velten M, Buemi A, Delafosse P, Maarouf N, Boutreux S, Launoy G

Br J Cancer. 2005 May 23;92(10):1842-5.

Are there regional differences in the management of colon cancer in France?

Phelip JM, Grosclaude P, Launoy G, Colonna M, Danzon A, Velten M, Tretarre B, Bouvier AM, Faivre J

Eur J Cancer Prev. 2005 Feb;14(1):31-7.

Social and geographical factors influencing the delay in treatment for colorectal cancer.

Dejardin O, Herbert C, Velten M, Buemi A, Menegoz F, Maarouf N, Launoy G

Br J Cancer. 2004 Nov 1;91(9):1751-2.

Incidence of gastrointestinal cancers in France.

Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buemi A, Tretarre B, Velten M, Dancourt V, Menegoz F, Guizard AV, Mace Lesec'h J, Peng J, Bercelli P, Arveux P, Esteve J, Faivre J

Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877-81.

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.

Petit T, Wilt M, Velten M, Millon R, Rodier JF, Borel C, Mors R, Haegele P, Eber M, Ghnassia JP

Eur J Cancer. 2004 Jan;40(2):205-11.

Cancer incidence and mortality in France over the period 1978-2000.

Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, Exbrayat C, Tretare B, Carli PM, Guizard AV, Troussard X, Bercelli P, Colonna M, Halna JM, Hedelin G, Mace-Lesec'h J, Peng J, Buemi A, Velten M, Jougla E, Arveux P, Le Bodic L, Michel E, Sauvage M, Schvartz C, Faivre J

Rev Epidemiol Sante Publique. 2003 Feb;51(1 Pt 1):3-30.

Pr VELTEN Michel

Fiche personne

coordonnées

Territoire

Statut

affiliation

équipes/plateformes

Projets

Publications